Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
DOW | Ann: Change of Share Registry Address | 04/07/25 | 0 | 89 | |||
|
|||||||
DOW | Ann: Downer sells 49% interest in Keolis Downer joint venture | 01/07/25 | 0 | 66 | |||
|
|||||||
DOW | Ann: Downer awarded AusNet gas services contract extension | 01/07/25 | 0 | 75 | |||
|
|||||||
DOW | Ann: SPH Notice - Allan Gray Australia Pty Ltd | 06:50 | 0 | 150 | |||
|
|||||||
DOW | Ann: Change in substantial holding | 06:50 | 0 | 78 | |||
|
|||||||
DOW | Ann: Refinancing $1B of Syndicated Sustainability Linked Loan | 23/06/25 | 0 | 65 | |||
|
|||||||
DOW | Ann: Retirement and appointment of Non-Executive Directors | 23/06/25 | 0 | 60 | |||
|
|||||||
DOW | Ann: Works Finance (NZ) Limited - ROADS rate reset | 16/06/25 | 0 | 81 | |||
|
See All Discussions